Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 20 of 25

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Measurement of a complement inhibitory protein following AAV.CR2-CR1 administration in a retinal degradation model of geographic atrophy (GA)

Angela Ambakhutwala; Kara Shumansky; Rachel Eclov; Michael Engles; Jessica Raubenolt; Ashlyn Bassiri; Sydney Tickle; Angela Yang; Leslee Arwood; Pilar Prentiss; Andrew Murphy

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1934.

ARVO Annual Meeting Abstract June 2024

Investigating the Efficacy of AAV Mediated Expression of CR2-CR1 fusion protein, a Complement Inhibitor, in Ameliorating Retinal Degeneration in Mice

Michael Engles; Rachel Eclov; Pilar Prentiss; Jessica Raubenolt; William Chappell; Jiewu Liu; Kara Shumansky; Angela Yang; Ashlyn Bassiri; Angela Ambakhutwala; Andrew Murphy; Lauren Parker; Benjamin Johnson

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3808.

ARVO Annual Meeting Abstract June 2024

Evaluation of AAV2 biodistribution after suprachoroidal injection in NHPs using a novel suprachoroidal delivery device system

Rachel Eclov; Michael Engles; Pilar Prentiss; Will Quinn; Dawn Fellner; Hagay Drori; Rob Damitz; Jiewu Liu; Ashlyn Bassiri; Yoreh Barak; Michele Stone

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5325.

ARVO Annual Meeting Abstract June 2021

Comparison of visual function in a non-human primate (NHP) model of retinal injury to human age-related macular degeneration (AMD) patients

Lakshmi Rajagopalan; William H Ridder; Kamal Dhakal; Corine Ghosn; Brooke Anders; Michael Engles

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2810.

ARVO Annual Meeting Abstract June 2020

Early structural and functional changes in a non-human primate model of glaucoma

Lakshmi Rajagopalan; Corine Ghosn; James A Burke; Michael Engles

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):274.

ARVO Annual Meeting Abstract June 2020

Tests That Differentiate Early AMD From Age Matched Control Patients.

William H Ridder; Caren Oquindo; Pat Yoshinaga; George Comer; Rima Khankan; Michael Engles; James A Burke

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3004.

ARVO Annual Meeting Abstract June 2020

Repeat intravitreal delivery of rAAV2 increases retinal ganglion cell transduction in non-human primate

David Lutz; Gerard A. Rodrigues; Mitalee Tamhane; Graeme Gardner; Michael Engles

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4478.

ARVO Annual Meeting Abstract July 2019

Cyto-/neuro-protective effects of brimonidine drug delivery system (DDS) in a nonhuman primate progressive retinal degeneration model of geographic atrophy (GA) secondary to age-related macular degeneration (AMD)

Lakshmi Rajagopalan; Corine Ghosn; Mitalee Tamhane; Ashutosh Kulkarni; Lori-Ann Christie; Francisco López; Michael Engles

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2993.

ARVO Annual Meeting Abstract July 2019

Intraocular pressure (IOP) lowering efficacy of Bimatoprost Sustained Release (BimSR) in dogs pretreated with selective laser trabeculoplasty (SLT)

Corine Ghosn; Michael Engles; Lakshmi Rajagopalan; Sveti Ugarte; Shruti Mistry; Werhner Orilla; Goodkin Margot; Michael R Robinson; Mohammed Dibas

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3779.

ARVO Annual Meeting Abstract July 2019

The effects of selective laser trabeculoplasty (SLT) in normotensive beagle dogs

Michael Engles; Corine Ghosn; Sveti Ugarte; Shruti Mistry; Werhner Orilla; Goodkin Margot; Mohammed Dibas; Michael R Robinson

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3796.

ARVO Annual Meeting Abstract September 2016

The Effect of Betadine on Vision and on Cornea in Rabbits

Kavita Dhamdhere; Alexandra S P Almazan; Michael Engles; James A Burke

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3855.

ARVO Annual Meeting Abstract March 2012

Assessing The Visual Benefit Of Macular Pigment On Targets Viewed Through Simulated Blue Haze And Achromatic Broadband Light

Laura M. Fletcher; Emily R. Bovier; Michael Engles; Billy R. Hammond

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3383.

ARVO Annual Meeting Abstract March 2012

The Contrast Sensitivity Function Measured under Blue Haze Conditions

Emily R. Bovier; Laura M. Fletcher; Michael Engles; Billy R. Hammond, Jr.

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4806.

ARVO Annual Meeting Abstract April 2010

Macular Pigment: Visual Effects of Deficiency

J. C. Wong; M. Engles; B. R. Wooten; K. J. O'Brien; B. R. Hammond, Jr.

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):1288.

ARVO Annual Meeting Abstract April 2009

Testing the Visibility Hypothesis of Macular Pigment Using a Filter That Simulates Changes in Macular Pigment Density

J. C. Wong; M. Engles; B. R. Wooten; B. R. Hammond, Jr.

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1704.

ARVO Annual Meeting Abstract April 2009

Contrast Thresholds in Infants Compared to Adults

M. J. Dengler; M. Engles; K. Varga; J. Frick; B. R. Hammond, Jr.

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1705.

OSA Fall Vision Meeting Abstract December 2008

Macular pigment and contrast sensitivity: Testing the acuity hypothesis

Michael Engles; Billy R. Hammond; Billy R. Wooten

Journal of Vision. 2008; 8(17):14. https://doi.org/10.1167/8.17.14

ARVO Annual Meeting Abstract May 2008

Evaluation of the Acuity Hypothesis of Macular Pigment Using an Assessment of the Entire Contrast Sensitivity Function

M. Engles; B. R. Hammond, Jr.; B. R. Wooten

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):4963.

Visual Psychophysics and Physiological Optics June 2007

Macular Pigment: A Test of the Acuity Hypothesis

PDF

Michael Engles; Billy Wooten; Billy Hammond
TAGS: pigment
Invest. Ophthalmol. Vis. Sci.. 2007; 48(6):2922-2931. https://doi.org/10.1167/iovs.06-0883

ARVO Annual Meeting Abstract May 2007

The Glare Hypothesis of Macular Pigment Function

J. M. Stringham; B. R. Hammond, Jr.; M. Engles

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):2146.

1 2

Next 20 Results »

Advertisement